Picture of BIOLASE logo

BIOL BIOLASE Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Annual cashflow statement for BIOLASE, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-16.9-21.5-17.9-16.8-16.2
Depreciation
Deferred Taxes
Non-Cash Items3.336.465.231.780.985
Unusual Items
Other Non-Cash Items
Changes in Working Capital-5.4-0.009-1.111.75-1.94
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-18.4-14.1-12.7-12.8-16.7
Capital Expenditures-0.747-0.558-0.207-0.096-0.707
Purchase of Fixed Assets
Other Investing Cash Flow Items00.0360
Sale of Fixed Assets
Cash from Investing Activities-0.747-0.522-0.207-0.096-0.707
Financing Cash Flow Items0-1.22-0.954-3.05-1.14
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities21.611.210.724.330
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash2.72-3.54-2.2511.812.3

Or unlock with your email

Or unlock with your email